tomeko

Chondrodysplasia punctata 2 X-linked dominant

Just diagnosed with Chondrodysplasia punctata 2 X-linked dominant?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Chondrodysplasia punctata 2 X-linked dominant, look for clinical trials, and connect with others living with it — all in one place.

Open the full Chondrodysplasia punctata 2 X-linked dominant hub →

Overview

Chondrodysplasia punctata 2 X-linked dominant is a rare condition. Also known as CDPX2, CDPXD, CPXD, Chondrodystrophia calcificans congenita, Conradi-Hünermann-Happle syndrome, X-linked chondrodysplasia punctata type 2. Tomeko brings together the specialists, research, clinical trials, treatments and community for Chondrodysplasia punctata 2 X-linked dominant so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:35173 · OMIM 302960 · ICD-10 Q77.3 · GARD 0006189

Find care for Chondrodysplasia punctata 2 X-linked dominant

Authoritative references for Chondrodysplasia punctata 2 X-linked dominant

Common questions

I was just diagnosed with Chondrodysplasia punctata 2 X-linked dominant — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Chondrodysplasia punctata 2 X-linked dominant, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Chondrodysplasia punctata 2 X-linked dominant?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Chondrodysplasia punctata 2 X-linked dominant, filtered to your area.

Are there clinical trials for Chondrodysplasia punctata 2 X-linked dominant?

Tomeko shows live, recruiting studies for Chondrodysplasia punctata 2 X-linked dominant from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com